Blog - INTERNET MÉDICA

■ Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosácea

Incel Uysal, Pinar et al.

An. Bras. Dermatol., Nov 2019, vol.94, no.6, p.704-709

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000600704&lng=en&nrm=iso

■ Rosacea: the patient experience is now ¨clear¨

M Schaller

EMJ Dermatol 2019; vol 7 (1): 52-59

https://www.emjreviews.com/rosacea-the-patient-experience-is-now-clear/

■ The pathogenic role of Demodex Mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea?

Fabienne M. N. Forton

Dermatol Ther (Heidelb) 2020 Dec; 10(6): 1229–1253

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649190/

■ Clinical picture, diagnosis and treatment of rosacea, complicated by Demodex mites

Alexey Kubanov, Yuliya Gallyamova, Anzhela Kravchenko

Dermatol Reports. 2019 Jan 23; 11(1): 7675

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452096/

■ Rosacea is characterized by a profoundly diminished skin barrier

B Medgyesi, Z Dajnoki, G Béke et al

Journal of Investigative Dermatology 2020, vol 140 (10)

https://www.jidonline.org/article/S0022-202X(20)31198-2/fulltext

■ Systemic steroids, clarithromycin and metronidazole in the treatment of rosacea during pregnancy

B M Clanner-Engleshofen, H Schwaiger, G Plewig et al

J Clin Case Rep 2018, vol 8: 4

https://www.hilarispublisher.com/open-access/systemic-steroids-clarithromycin-and-metronidazole-in-the-trea-tmentof-rosacea-during-pregnancy-2165-7920-10001100.pdf

■ A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulostular rosacea

Webster, Z.D. Draelos, E. Graber, et al

Br J Dermatol. 2020 Sep; 183(3): 471–479

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496252/

■ A case of pediatric rosacea – skin and ocular involvement

Xue Ting Ooi, Kong Bing Tan, Nisha Chandran

Clin Case Rep. 2019 Dec; 7(12): 2414–2416

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935648/

■ Rosacea-specific quality of life questionnaire: translation, cultural adaptation and validation for Brazilian Portuguese

Tannus, Flávia Cisi et al.

An. Bras. Dermatol., Dec 2018, vol.93, no.6, p.836-842

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000600836&lng=en&nrm=iso

■ Dr Paulo Fernando Leite

– Cardiologia/Prevenção Cardiovascular

– Educação Médica Online

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: dezembro 2020

COVID-19: Manifestações Oftalmológicas (COVID-19: Ocular Implications)

Por Paulo Leite 12/12/2020

■ Hydroxychloroquine and chloroquine retinal safety concers durign COVID-19 outbreak

Massimo Nicolò, Lorenzo Ferro Desideri, Matteo Bassetti, Carlo Enrico Traverso

Int Ophthalmol. 2020 Sep 18 : 1–7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499926/

■ Acute chloroquine and hydroxychloroquine toxicity: a review for emergency clinicians

Alessandra Della Porta, Kasha Bornstein, Austin Coye et al

Am J Emerg Med. 2020 Oct; 38(10): 2209–2217

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369162/

■ Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavírus COVID-19

J.A. Gegúndez-Fernández, J. Zarranz-Ventura, G. Garay-Aramburu, ET AL

Sociedades oftalmológicas españolas

Arch Soc Esp Oftalmol. 2020 Jun; 95(6): 300–310

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183292/

■ COVID-19 and ocular implications: an update

Raffaele Nuzzi, Luigi Ludovico Carucci, Flavia Tripoli

J Ophthalmic Inflamm Infect. 2020; 10: 20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471234/

■ The ocular surface, coronaviruses and COVID-19

Mark DP Willcox, Karen Walsh, Jason J Nichols et al

Clin Exp Optom. 2020 May 13 : 10.1111/cxo.13088

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272971/

■ Are eyes the windows to COVID-19? Systemic review and meta-analysis

Rina La Distia Nora, Ikhwanuliman Putera, Dhiya Farah Khalisha et al

BMJ Open Ophthalmol. 2020; 5(1): e000563

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476422/

■ Ocular findings in COVID-19 patients: a review of direct manifestationns and indirect effects on the eye

Federica Bertoli, Daniele Veritti, Carla Danese et al

J Ophthalmol. 2020; 2020: 4827304.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491448/

■ COVID-19: Ophthalmological aspects of the SARS-CoV 2 global pandemic

Jakob Siedlecki, Victor Brantl, Benedikt Schworm et al

Klin Monbl Augenheilkd. 2020 May; 237(5): 675–680

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295305/

■ Retinal findings in patients with COVID-19: Results from the SERPICO-19 study

Alessandro Invernizzi, Alessandro Torre, Salvatore Parrulli et al

EClinicalMedicine. 2020 Oct; 27: 100550.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502280/

■ The ocular manifestations and transmission of COVID-19: Recommendations for prevention

Dominique M. Dockery, Susannah G. Rowe, Marjorie A. Murphy, Magdalena G. Krzystolik

J Emerg Med. 2020 Jul; 59(1): 137–140

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205711/

■ Diabetic retinopathy screening and the COVID-19 pandemic in Brazil

Malerbi, Fernando Korn, Morales, Paulo Henrique Avila and Regatieri, Caio Vinicius Saito

Arq. Bras. Oftalmol., Aug 2020, vol.83, no.4, p.V-VI

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492020000400001&lng=pt&nrm=iso

■ COVID-19 and the eye: how much do we really know? A best evidence review.

Emparan, Juan Pablo Olivares-de et al.

Arq. Bras. Oftalmol., June 2020, vol.83, no.3, p.250-261

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492020000300016&lng=pt&nrm=iso&tlng=en

■ Implications of Covid-19 in ophthalmology

Pereira, André Luiz Netto et al.

Rev. bras.oftalmol., June 2020, vol.79, no.3, p.217-217

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000300217&lng=pt&nrm=iso